AU2001232951A1 - Combination of temozolomide and pegylated interferon-alpha for treating cancer - Google Patents

Combination of temozolomide and pegylated interferon-alpha for treating cancer

Info

Publication number
AU2001232951A1
AU2001232951A1 AU2001232951A AU3295101A AU2001232951A1 AU 2001232951 A1 AU2001232951 A1 AU 2001232951A1 AU 2001232951 A AU2001232951 A AU 2001232951A AU 3295101 A AU3295101 A AU 3295101A AU 2001232951 A1 AU2001232951 A1 AU 2001232951A1
Authority
AU
Australia
Prior art keywords
temozolomide
alpha
combination
treating cancer
pegylated interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232951A
Inventor
Sara L. Zaknoen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001232951A1 publication Critical patent/AU2001232951A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001232951A 2000-01-24 2001-01-22 Combination of temozolomide and pegylated interferon-alpha for treating cancer Abandoned AU2001232951A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17762400P 2000-01-24 2000-01-24
US60177624 2000-01-24
PCT/US2001/002374 WO2001052882A1 (en) 2000-01-24 2001-01-22 Combination of temozolomide and pegylated interferon-alpha for treating cancer

Publications (1)

Publication Number Publication Date
AU2001232951A1 true AU2001232951A1 (en) 2001-07-31

Family

ID=22649305

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232951A Abandoned AU2001232951A1 (en) 2000-01-24 2001-01-22 Combination of temozolomide and pegylated interferon-alpha for treating cancer

Country Status (7)

Country Link
US (1) US20020009428A1 (en)
EP (1) EP1251866A1 (en)
JP (1) JP2003520247A (en)
AU (1) AU2001232951A1 (en)
CA (1) CA2397793A1 (en)
MX (1) MXPA02007172A (en)
WO (1) WO2001052882A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642211B2 (en) * 2001-04-06 2003-11-04 Wisconsin Alumni Research Foundation Treatment of cancer with thymidine in combination with temozolamide
US20050123397A1 (en) * 2003-12-03 2005-06-09 Mcardle Nathan J. Compressor diffuser
US20050123394A1 (en) * 2003-12-03 2005-06-09 Mcardle Nathan J. Compressor diffuser
EP1706399A1 (en) * 2004-01-23 2006-10-04 Elan Pharmaceuticals, Inc. Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
KR101438036B1 (en) * 2006-09-29 2014-09-04 씨아이피엘에이 엘티디. An improved process for the preparation of temozolomide and analogs
US20080319039A1 (en) * 2007-06-25 2008-12-25 Jacqueline Rose Bersch Unit dosage forms of temozolomide
US20090270397A1 (en) * 2008-04-08 2009-10-29 Orlow Seth J Methods and compositions for the treatment of cancers, such as melanomas and gliomas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
AU691225B2 (en) * 1993-11-10 1998-05-14 Schering Corporation Improved interferon polymer conjugates
AU719074B2 (en) * 1995-10-04 2000-05-04 Schering Corporation Combination of temozolomide and alpha-IFN for the treatment of advanced cancer
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
KR100420642B1 (en) * 1998-03-26 2004-03-02 쉐링 코포레이션 Formulations for protection of peg-interferon alpha conjugates

Also Published As

Publication number Publication date
US20020009428A1 (en) 2002-01-24
WO2001052882A1 (en) 2001-07-26
CA2397793A1 (en) 2001-07-26
MXPA02007172A (en) 2002-12-13
EP1251866A1 (en) 2002-10-30
JP2003520247A (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
AU2002258399A1 (en) Use of trail and antiprogestins for treating cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
PL352931A1 (en) Compositions and uses of et743 for treating cancer
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
HUP0300848A3 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
EP1463495A4 (en) Agents and methods for treatment of cancer
EP1294949A4 (en) Human tumor necrosis factor delta and epsilon
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU3896900A (en) Treatment of pain
AU2001232951A1 (en) Combination of temozolomide and pegylated interferon-alpha for treating cancer
HK1044111A1 (en) Improved cancer treatment with temozolomide
EP1176940A4 (en) Fingernail hardening treatment
IL154354A0 (en) Composition for prophylaxis and treatment of cancer
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
EP1173189A4 (en) Asialocytokines and treatment of liver disease
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
AU2001258575A1 (en) Treatment of cancer and neurological diseases